Joseph Cacchione, MD, has signed a five-year contract extension to remain CEO of Philadelphia-based Jefferson Health through 2029.
Jefferson’s board unanimously approved the extension, according to a May 28 health system news release. His previous contract was set to expire at the end of 2027, a Jefferson spokesperson confirmed to Becker’s.
Dr. Cacchione became CEO in 2022. Under his leadership, the $15.5 billion system has grown to 65,000 employees, 700 sites of care and 32 hospitals.
Milestones of his tenure include the August merger with Allentown, Pa.-based Lehigh Valley Health Network, and securing $300 million in philanthropic support for the system, including a $50 million gift for the Honickman Center.
The contract extension follows the May 1 appointment of Michael Harrington as Jefferson’s executive vice president and CFO.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
